These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 1407002
1. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Monnet FP, Blier P, Debonnel G, de Montigny C. Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):32-9. PubMed ID: 1407002 [Abstract] [Full Text] [Related]
2. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Monnet FP, de Costa BR, Bowen WD. Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358 [Abstract] [Full Text] [Related]
3. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin. Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C. Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892 [Abstract] [Full Text] [Related]
4. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Monnet FP, Mahé V, Robel P, Baulieu EE. Proc Natl Acad Sci U S A; 1995 Apr 25; 92(9):3774-8. PubMed ID: 7731982 [Abstract] [Full Text] [Related]
5. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus. Bergeron R, de Montigny C, Debonnel G. Br J Pharmacol; 1997 Apr 25; 120(7):1351-9. PubMed ID: 9105712 [Abstract] [Full Text] [Related]
6. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. Bergeron R, de Montigny C, Debonnel G. J Neurosci; 1996 Feb 01; 16(3):1193-202. PubMed ID: 8558248 [Abstract] [Full Text] [Related]
7. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. Monnet FP, Debonnel G, Fournier A, de Montigny C. J Pharmacol Exp Ther; 1992 Dec 01; 263(3):1219-25. PubMed ID: 1469630 [Abstract] [Full Text] [Related]
8. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning. Debonnel G, Bergeron R, Monnet FP, De Montigny C. Neuroscience; 1996 Apr 01; 71(4):977-87. PubMed ID: 8684626 [Abstract] [Full Text] [Related]
9. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus. Monnet FP, Debonnel G, de Montigny C. Synapse; 1993 Jan 01; 13(1):30-8. PubMed ID: 8427011 [Abstract] [Full Text] [Related]
10. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Gronier B, Debonnel G. Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654 [Abstract] [Full Text] [Related]
11. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices. Pittaluga A, Bonfanti A, Arvigo D, Raiteri M. Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr 05; 359(4):272-9. PubMed ID: 10344525 [Abstract] [Full Text] [Related]
12. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors. Bergeron R, Debonnel G. Psychopharmacology (Berl); 1997 Feb 05; 129(3):215-24. PubMed ID: 9084059 [Abstract] [Full Text] [Related]
13. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL. Brain Res; 1991 Apr 19; 546(2):282-6. PubMed ID: 1676927 [Abstract] [Full Text] [Related]
14. Effect of 1-aminocyclopropanecarboxylic acid on N-methyl-D-aspartate-stimulated [3H]-noradrenaline release in rat hippocampal synaptosomes. Clos MV, Garcia Sanz A, Trullas R, Badia A. Br J Pharmacol; 1996 Jun 19; 118(4):901-4. PubMed ID: 8799560 [Abstract] [Full Text] [Related]
15. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. Monnet FP, Debonnel G, de Montigny C. J Pharmacol Exp Ther; 1992 Apr 19; 261(1):123-30. PubMed ID: 1532832 [Abstract] [Full Text] [Related]
16. Terminal serotonin autoreceptor function in the rat hippocampus is not modified by pertussis and cholera toxins. Blier P. Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug 19; 344(2):160-6. PubMed ID: 1944610 [Abstract] [Full Text] [Related]
17. Roles for nitric oxide as an intra- and interneuronal messenger at NMDA release-regulating receptors: evidence from studies of the NMDA-evoked release of [3H]noradrenaline and D-[3H]aspartate from rat hippocampal slices. Jones NM, Loiacono RE, Beart PM. J Neurochem; 1995 May 19; 64(5):2057-63. PubMed ID: 7536805 [Abstract] [Full Text] [Related]
18. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Pittaluga A, Raiteri M. Eur J Neurosci; 1994 Nov 01; 6(11):1743-9. PubMed ID: 7874313 [Abstract] [Full Text] [Related]
19. Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus. Gronier B, Debonnel G. Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar 01; 353(4):382-90. PubMed ID: 8935704 [Abstract] [Full Text] [Related]
20. Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites. Chaki S, Okuyama S, Ogawa S, Tomisawa K. Neurochem Int; 1998 Jul 01; 33(1):29-34. PubMed ID: 9694039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]